FIELD: medicine.
SUBSTANCE: invention relates to compounds or their pharmaceutically acceptable salts having structures represented below, where X is O or CH2. The invention also relates to a pharmaceutical composition for the treatment of opioid addiction, based on the specified compounds.
EFFECT: new compounds and a pharmaceutical composition based on them are obtained, which provide long-term, slowed down, and controlled release of antagonists of opioid nalmefene and naltrexone receptors, when administered to the body.
15 cl, 34 dwg, 31 tbl, 35 ex
Title | Year | Author | Number |
---|---|---|---|
PRODRUGS OF OPIOID RECEPTOR ANTAGONISTS | 2019 |
|
RU2799339C2 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
NOVEL SUBSTITUTED TETRACYCLIC DERIVATIVES OF TETRAHYDROPYRAN, PYRROLIDINE AND TETRAHYDROTHIOPHENE | 2005 |
|
RU2401257C2 |
CONDENSED INDAN COMPOUNDS | 2008 |
|
RU2451671C2 |
Authors
Dates
2022-12-13—Published
2018-11-03—Filed